Skip Navigation
Skip to contents

대한치매학회

검색

대한치매학회 검색

일반인 공간

학회지

권호별 검색

  • HOME
  • 학회지
  • 학회지
  • 권호별 검색
Review
Dementia and Neurocognitive Disorders 2020: 19: 2: 1-15

전문보기
Executive Summary of the 2019 International Conference of Korean Dementia Association: Exploring the Novel Concept of Alzheimer's Disease and Other Dementia: a Report from the Academic Committee of the Korean Dementia Association
Kee Hyung Park , 1 Jae-Sung Lim , 2 Sang Won Seo , 3 Yong Jeong , 4 Young Noh , 1 Seong-Ho Koh , 5 Jae-sung Bae , 6 Sun Ah Park , 7 Soh-Jeong Yang , 8 Hee Jin Kim , 3 Juhee Chin , 3 Jee-hoon Roh , 9 Seong Soo A. An , 10 on behalf of Academic Committee of the Korean Dementia Association
Department of Neurology, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea 2 Department of Neurology, Hallym University Sacred Heart Hospital, Hallym Neurological Institute, Hallym University College of Medicine, Anyang, Korea 3 Department of Neurology, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Korea 4 Department of Bio and Brain Engineering, KAIST, Daejeon, Korea 5 Department of Neurology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea 6 Department of Physiology, Cell and Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu, Korea 7 Lab for Neurodegenerative Dementia, Department of Anatomy and Department of Neurology, Ajou University School of Medicine, Suwon, Korea 8 Department of Neurology, Yonsei University Health System, Seoul, Korea 9 Department of Neurology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea 10Department of Bionano Technology, Gachon University, Seongnam, Korea
Executive Summary of the 2019 International Conference of Korean Dementia Association: Exploring the Novel Concept of Alzheimer's Disease and Other Dementia: a Report from the Academic Committee of the Korean Dementia Association
Kee Hyung Park , 1 Jae-Sung Lim , 2 Sang Won Seo , 3 Yong Jeong , 4 Young Noh , 1 Seong-Ho Koh , 5 Jae-sung Bae , 6 Sun Ah Park , 7 Soh-Jeong Yang , 8 Hee Jin Kim , 3 Juhee Chin , 3 Jee-hoon Roh , 9 Seong Soo A. An , 10 on behalf of Academic Committee of the Korean Dementia Association
Department of Neurology, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea 2 Department of Neurology, Hallym University Sacred Heart Hospital, Hallym Neurological Institute, Hallym University College of Medicine, Anyang, Korea 3 Department of Neurology, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Korea 4 Department of Bio and Brain Engineering, KAIST, Daejeon, Korea 5 Department of Neurology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea 6 Department of Physiology, Cell and Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu, Korea 7 Lab for Neurodegenerative Dementia, Department of Anatomy and Department of Neurology, Ajou University School of Medicine, Suwon, Korea 8 Department of Neurology, Yonsei University Health System, Seoul, Korea 9 Department of Neurology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea 10Department of Bionano Technology, Gachon University, Seongnam, Korea
Because of repeated failures of clinical trials, the concept of Alzheimer's disease (AD) has been changing rapidly in recent years. As suggested by the National Institute on Aging and the Alzheimer's Association Research Framework, the diagnosis and classification of AD is now based on biomarkers rather than on symptoms, allowing more accurate identification of proper candidates for clinical trials by pathogenesis and disease stage. Recent development in neuroimaging has provided a way to reveal the complex dynamics of amyloid and tau in the
brain in vivo, and studies of blood biomarkers are taking another leap forward in diagnosis and treatment of AD. In the field of basic and translational research, the development of animal models and a deeper understanding of the role of neuroinflammation are taking a step closer to clarifying the pathogenesis of AD. Development of big data and the Internet
of Things is also incorporating dementia care and research into other aspects. Large-scale genetic research has identified genetic abnormalities that can provide a foundation
for precision medicine along with the aforementioned digital technologies. Through the first international conference of the Korean Dementia Association, experts from all over the world gathered to exchange opinions with association members on these topics. The Academic Committee of the Korean Dementia Association briefly summarizes the contents of the lectures to convey the depth of the conference and discussions. This will be an important milestone in understanding the latest trends in AD's pathogenesis, diagnostic and therapeutic research and in establishing a future direction.
Key Words: Alzheimer Disease; Neuroinflammation; Translational Medical Research; Biomarkers; Genetic Research; Neuropsychology
대한치매학회지 (Dementia and Neurocognitive Disorders)

목록

더보기

Sponsor
  • 대웅제약
  • 에자이
  • 종근당
  • 명인제약
  • 유한양행
  • 룬드백
  • 제일
  • SK케미컬
  • 한독
  • 알보젠

더보기 닫기

  • 대웅제약
  • 에자이
  • 종근당
  • 명인제약
  • 유한양행
  • 룬드백
  • SK케미컬
  • 한독
서울특별시 서초구 서초중앙로 18 (서초동, 서초쌍용플래티넘) 619호
  • Tel : +82-2-587-7462
  • e-mail : secretkda@thedementia.co.kr
  • 사업자등록번호 : 214-82-63838
  • 상호 : 대한치매학회
  • 대표자명 : 최성혜 이사장

Copyright © The Korean Dementia Association, All rights reserved